Foghorn Therapeutics Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-31.3M | $-47.5M | $16.2M | $3.0M |
| FY2021 | $-50.3M | $-53.6M | $3.3M | $8.4M |
| FY2022 | $193.6M | $192.4M | $1.2M | $14.3M |
| FY2023 | $-118.1M | $-119.3M | $1.2M | $16.2M |
| FY2024 | $-100.4M | $-101.3M | $906.0K | $11.9M |